These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7585165)

  • 21. DHHS proposes new HIV-AIDS treatment guidelines.
    Public Health Rep; 1997; 112(5):359-60. PubMed ID: 9323383
    [No Abstract]   [Full Text] [Related]  

  • 22. New AIDS drug poised to move into development.
    Science; 1991 Dec; 254(5039):1715. PubMed ID: 1763318
    [No Abstract]   [Full Text] [Related]  

  • 23. USA: drug firms to collaborate in AIDS trials.
    McCarthy M
    Lancet; 1993 May; 341(8853):1141-2. PubMed ID: 8097819
    [No Abstract]   [Full Text] [Related]  

  • 24. From the Food and Drug Administration. Update on zidovudine.
    Nightingale SL
    JAMA; 1988 Aug; 260(7):898. PubMed ID: 3165139
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA panel unanimously recommends approval of Vistide for CMV retinitis. Food and Drug Administration.
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50. PubMed ID: 11363532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Didanosine and foscarnet marketed for use by patients with AIDS.
    Clin Pharm; 1992 Jan; 11(1):4, 6. PubMed ID: 1309689
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA expands testing of anti-AIDS drugs.
    N Y State J Med; 1989 Sep; 89(9):548. PubMed ID: 2552360
    [No Abstract]   [Full Text] [Related]  

  • 28. Committee recommends approval of AIDS drug.
    Minn Med; 1994 Jul; 77(7):55. PubMed ID: 8052209
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA 'remains committed' to quick approval of AIDS drugs.
    Am Pharm; 1994 Dec; NS34(12):14. PubMed ID: 7856502
    [No Abstract]   [Full Text] [Related]  

  • 30. The National Task Force on AIDS Drug Development: a progress report.
    Levin J
    BETA; 1995 Jun; ():62-3. PubMed ID: 11362547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IRB/FDA requirements relevant to HIV/AIDS clinical trials in correctional settings.
    Cohen J;
    AIDS Read; 2001 Jan; 11(1):41-2. PubMed ID: 11215087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activists now urge caution on approval of new AIDS drug.
    MacIlwain C
    Nature; 1993 Sep; 365(6445):378. PubMed ID: 8413575
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral prodrug of ganciclovir approved for CMV retinitis.
    Am J Health Syst Pharm; 2001 Jun; 58(11):946, 948. PubMed ID: 11402485
    [No Abstract]   [Full Text] [Related]  

  • 34. AIDS drugs in development. Facts and comparisons.
    Hosp Pharm; 1993 Feb; 28(2):161, 165-7. PubMed ID: 10125704
    [No Abstract]   [Full Text] [Related]  

  • 35. [Patients exert pressure. Is drug approval to be accelerated?].
    Rautenstrauch J
    Dtsch Med Wochenschr; 2000 Oct; 125(41):A13. PubMed ID: 11076257
    [No Abstract]   [Full Text] [Related]  

  • 36. AIDS buyers' clubs.
    DeChristoforo R; Minor JR
    Am J Health Syst Pharm; 1997 Sep; 54(18):2122-4. PubMed ID: 9377212
    [No Abstract]   [Full Text] [Related]  

  • 37. Abandoning hopelessness. Reform of the U.S. Food and Drug Administration (FDA).
    Baker R
    BETA; 1995 Dec; ():6-7. PubMed ID: 11363013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDA approves AIDS drug.
    Am Pharm; 1992 Sep; NS32(9):13-4. PubMed ID: 1332462
    [No Abstract]   [Full Text] [Related]  

  • 39. AIDS Activists, FDA Regulation, and the Amendment of America's Drug Constitution.
    Grossman LA
    Am J Law Med; 2016 Nov; 42(4):687-742. PubMed ID: 29086653
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV surrogate markers weighed.
    Cotton P
    JAMA; 1991 Mar; 265(11):1357, 1361-2. PubMed ID: 1671883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.